moxifloxacin &#160; Turanci (Q424940)

retrieved ^Turanci

27 Faburairu 2018

heterocyclic compound ^Turanci

0 references

carbocyclic compound ^Turanci

0 references

amfani

magani

1 reference

Moxifloxacin (Turanci)

stated in ^Turanci

DrugBank ^Turanci

Aspergillus austroafricanus

17 Nuwamba 2015

DrugBank ID ^Turanci

00218

image of molecular model or crystal lattice model ^Turanci

Moxifloxacin-cation-from-xtal-3D-balls.png
1,100 × 904; 218 KB

depicts ^Turanci

ball-and-stick model ^Turanci

0 references

Taro

401.175 dalton

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

moxifloxacin (Turanci)

retrieved ^Turanci

19 Oktoba 2016

sinadaran dabara

C₂₁H₂₄FN₃O₄

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

moxifloxacin (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

canonical SMILES ^Turanci

COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

moxifloxacin (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

isomeric SMILES ^Turanci

COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

moxifloxacin (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

active ingredient in ^Turanci

Moxeza ^Turanci

1 reference

stated in ^Turanci

RxNorm ^Turanci

RxNorm ID ^Turanci

1047505

retrieved ^Turanci

14 Faburairu 2018

Avelox ^Turanci

1 reference

stated in ^Turanci

RxNorm ^Turanci

RxNorm ID ^Turanci

261456

retrieved ^Turanci

14 Faburairu 2018

Vigamox ^Turanci

1 reference

stated in ^Turanci

RxNorm ^Turanci

RxNorm ID ^Turanci

405392

retrieved ^Turanci

14 Faburairu 2018

World Health Organisation international non-proprietary name ^Turanci

moxifloxacin (Turanci)

1 reference

stated in ^Turanci

ChEBI ^Turanci

ChEBI ID ^Turanci

moxifloxacin (Turanci)

retrieved ^Turanci

19 Oktoba 2016

found in taxon ^Turanci

1 reference

stated in ^Turanci

Metabolites from the Fungal Endophyte Aspergillus austroafricanus in Axenic Culture and in Fungal-Bacterial Mixed Cultures ^Turanci

medical condition treated ^Turanci

Escherichia coli infectious disease ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

bacteroides infectious disease ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

ciwon filin fitsari

2 references

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

sinusitis ^Turanci

2 references

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

bacterial pneumonia ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

Ciwon sanyi

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

acute bronchitis ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

upper respiratory tract infection ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

cystitis ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

pyelonephritis ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

gram-negative bacterial infection ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

staphylococcal infection ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

Pseudomonas infection ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

13 Disamba 2016

Conjunctivitis

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

Ciwon huhu

1 reference

stated in ^Turanci

retrieved ^Turanci

2 Oktoba 2018

significant drug interaction ^Turanci

amiodarone ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

anagrelide ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

arsenic trioxide ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

astemizole ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

azithromycin ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

bepridil ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

chloroquine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

chlorpromazine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

cisapride ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

(RS)-citalopram ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

clarithromycin ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

cocaine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

disopyramide ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

dofetilide ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

domperidone ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

dronedarone ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

droperidol ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

erythromycin ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

escitalopram ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

flecainide ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

halofantrine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

haloperidol ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

ibutilide ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

mesoridazine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

(RS)-methadone ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

https://www.drugs.com/drug-interactions/methadone-index.html

ondansetron ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

pentamidine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

pimozide ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

probucol ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

procainamide ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

quinidine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

sevoflurane ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

sotalol ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

sparfloxacin ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

(RS)-sulpiride ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

terfenadine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

thioridazine ^Turanci

1 reference

stated in ^Turanci

High-priority drug–drug interactions for use in electronic health records ^Turanci

(RS)-citalopram ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ondansetron ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-methadone ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

amiodarone ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

arsenic trioxide ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

disopyramide ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

toremifene ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

sotalol ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

erythromycin ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

clarithromycin ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

dronedarone ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

vandetanib ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

crizotinib ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

droperidol ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pimozide ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

haloperidol ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

chlorpromazine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

clomipramine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

zuclopenthixol ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pasireotide ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-hydroxyzine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-sulpiride ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

anagrelide ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

pentamidine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

mefloquine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

domperidone ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fingolimod ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

methylprednisolone ^Turanci

Achor-Smith syndrom ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

dexamethasone ^Turanci

Achor-Smith syndrom ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

Prednisolone

Achor-Smith syndrom ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

prednisone ^Turanci

Achor-Smith syndrom ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fludrocortisone ^Turanci

Achor-Smith syndrom ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

triamcinolone ^Turanci

Achor-Smith syndrom ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

betamethasone ^Turanci

Achor-Smith syndrom ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

budesonide ^Turanci

Achor-Smith syndrom ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

cortisol ^Turanci

Achor-Smith syndrom ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ivabradine ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ivabradine ^Turanci

long QT syndrome ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

(RS)-sulpiride ^Turanci

torsades de pointes ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

rac-warfarin ^Turanci

retroperitoneal hemorrhage ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

methylprednisolone ^Turanci

tendon rupture ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

dexamethasone ^Turanci

tendon rupture ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

Prednisolone

tendon rupture ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

prednisone ^Turanci

tendon rupture ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fludrocortisone ^Turanci

tendon rupture ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

triamcinolone ^Turanci

tendon rupture ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

betamethasone ^Turanci

tendon rupture ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

budesonide ^Turanci

tendon rupture ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

cortisol ^Turanci

tendon rupture ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

legal status (medicine) ^Turanci

boxed warning ^Turanci

1 reference

https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/343802

InChI=1S/C21H24FN3O4/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28)/t11-,16+/m0/s1

FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links. (Turanci)

pregnancy category ^Turanci

Australian pregnancy category B3 ^Turanci

1 reference

an ɗauko daga

English Wikipedia ^Turanci

US pregnancy category C ^Turanci

1 reference

an ɗauko daga

English Wikipedia ^Turanci

subject has role ^Turanci

antibiotic ^Turanci

1 reference

stated in ^Turanci

Medical Subject Headings ^Turanci

MeSH descriptor ID ^Turanci

C104727

retrieved ^Turanci

15 Maris 2018

topoisomerase II inhibitor ^Turanci

1 reference

stated in ^Turanci

Medical Subject Headings ^Turanci

MeSH descriptor ID ^Turanci

C104727

retrieved ^Turanci

15 Maris 2018

essential medicine ^Turanci

0 references

bactericide ^Turanci

1 reference

stated in ^Turanci

ChEBI ^Turanci

ChEBI ID ^Turanci

63611

‎WHO Aware Classification ^Turanci

watch ^Turanci

1 reference

stated in ^Turanci

2023 ‎AWaRe classification‎ ^Turanci

has part(s) ^Turanci

N

0 references

fluorine ^Turanci

0 references

C

0 references

Commons category ^Turanci

Moxifloxacin

0 references

Identifiers

InChI ^Turanci

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

moxifloxacin (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

InChIKey ^Turanci

2 references

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

moxifloxacin (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

stated in ^Turanci

ChEBI release 2020-09-01 ^Turanci

CAS Registry Number ^Turanci

151096-09-2

2 references

stated in ^Turanci

UNII ^Turanci

moxifloxacin (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

InChIKey ^Turanci

stated in ^Turanci

CAS Common Chemistry ^Turanci

retrieved ^Turanci

9 Afirilu 2021

https://commonchemistry.cas.org/detail?cas_rn=151096-09-2

ChemSpider ID ^Turanci

134802

1 reference

stated in ^Turanci

ChemSpider ^Turanci

ChemSpider ID ^Turanci

Moxifloxacin (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

PubChem CID ^Turanci

152946

2 references

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

moxifloxacin (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

InChIKey ^Turanci

40467042

1 reference

InChIKey ^Turanci

Reaxys registry number ^Turanci

8365827

1 reference

stated in ^Turanci

ChEBI ^Turanci

ChEBI ID ^Turanci

moxifloxacin (Turanci)

retrieved ^Turanci

19 Oktoba 2016

ChEBI ID ^Turanci

63611

mapping relation type ^Turanci

exact match ^Turanci

3 references

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

MOXIFLOXACIN (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

stated in ^Turanci

ChEBI release 2019-10-02 ^Turanci

InChI=1S/C21H24FN3O4/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28)/t11-,16+/m0/s1

International Chemical Identifier ^Turanci

InChI ^Turanci

ChEMBL ID ^Turanci

CHEMBL32

1 reference

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

MOXIFLOXACIN (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

SureChEMBL ID ^Turanci

SCHEMBL24007

2 references

based on heuristic ^Turanci

inferred from InChIKey ^Turanci

InChIKey ^Turanci

splash10-0gx0-0059300000-a3355cdb8ee9c8465fc3

UniChem compound ID ^Turanci

26129

1 reference

stated in ^Turanci

UniChem ^Turanci

SPLASH ^Turanci

0 references

HSDB ID ^Turanci

8026

1 reference

stated in ^Turanci

Hazardous Substances Data Bank ^Turanci

HSDB ID ^Turanci

8026

28 Oktoba 2019

Moxifloxacin (Turanci)

retrieved ^Turanci

10 Mayu 2021

DSSTox substance ID ^Turanci

DTXSID3048491

2 references

stated in ^Turanci

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard ^Turanci

InChIKey ^Turanci

DSSTOX compound identifier ^Turanci

DTXCID9028465

0 references

EC number ^Turanci

604-773-0

1 reference

stated in ^Turanci

ECHA Substance Infocard database ^Turanci

ECHA Substance Infocard ID ^Turanci

100.129.459

retrieved ^Turanci

27 Disamba 2018

1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid (Turanci)

quotation ^Turanci

CAS no.: 151096-09-2 (Turanci)

ECHA Substance Infocard ID ^Turanci

100.129.459

1 reference

stated in ^Turanci

ECHA Substance Infocard database ^Turanci

ECHA Substance Infocard ID ^Turanci

100.129.459

retrieved ^Turanci

27 Disamba 2018

1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid (Turanci)

quotation ^Turanci

CAS no.: 151096-09-2 (Turanci)

Lambar ATC

J01MA14

1 reference

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

Moxifloxacin (Turanci)

17 Nuwamba 2015

S01AE07

1 reference

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

Moxifloxacin (Turanci)

D03.633.100.810.835.322.327

17 Nuwamba 2015

Guide to Pharmacology Ligand ID ^Turanci

10915

1 reference

stated in ^Turanci

IUPHAR/BPS Guide to PHARMACOLOGY ^Turanci

retrieved ^Turanci

5 Faburairu 2021

MeSH descriptor ID ^Turanci

D000077266

subject named as ^Turanci

Moxifloxacin

0 references

Lambar itace MeSH

0 references

RxNorm ID ^Turanci

139462

1 reference

stated in ^Turanci

UNII ^Turanci

moxifloxacin (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

DrugBank ID ^Turanci

DB00218

1 reference

InChIKey ^Turanci

Human Metabolome Database ID ^Turanci

HMDB0014363

2 references

based on heuristic ^Turanci

inferred from InChIKey ^Turanci

InChIKey ^Turanci

UNII ^Turanci

U188XYD42P

2 references

stated in ^Turanci

UNII ^Turanci

moxifloxacin (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

InChIKey ^Turanci

MedlinePlus drug identifier ^Turanci

a600002

route of administration ^Turanci

oral administration ^Turanci

0 references

a608030

route of administration ^Turanci

intravenous injection ^Turanci

0 references

a605016

route of administration ^Turanci

eye contact ^Turanci

0 references

NIAID ChemDB ID ^Turanci

070017

1 reference

an ɗauko daga

English Wikipedia ^Turanci

NDF-RT ID ^Turanci

1 reference

stated in ^Turanci

UNII ^Turanci

moxifloxacin (Turanci)

retrieved ^Turanci

19 Nuwamba 2016

Probes And Drugs ID ^Turanci

PD010166

0 references

DrugCentral ID ^Turanci

1854

1 reference

stated in ^Turanci

UniChem ^Turanci

KEGG ID ^Turanci

D08237

1 reference

stated in ^Turanci

ChEBI ^Turanci

ChEBI ID ^Turanci

moxifloxacin (Turanci)

retrieved ^Turanci

19 Oktoba 2016

PDB ligand ID ^Turanci

MFX

0 references

CAB ID ^Turanci

160587

1 reference

stated in ^Turanci

CAB Thesaurus ^Turanci

retrieved ^Turanci

6 Afirilu 2020

DeCS ID ^Turanci

57569

0 references

electronic Essential Medicines List medicine ID ^Turanci

354

0 references

Freebase ID ^Turanci

/m/098_pc

1 reference

stated in ^Turanci

Freebase Data Dumps ^Turanci

28 Oktoba 2013

Microsoft Academic ID ^Turanci

2778836808

0 references

OpenAlex ID ^Turanci

C2778836808

1 reference

stated in ^Turanci

OpenAlex ^Turanci

retrieved ^Turanci

26 Janairu 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

PDB structure ID ^Turanci

4Z3O

1 reference

stated in ^Turanci

Protein Data Bank ^Turanci

PDB structure ID ^Turanci

4Z3O (Turanci)

retrieved ^Turanci

19 Oktoba 2016

2XKK

1 reference

stated in ^Turanci

Protein Data Bank ^Turanci

PDB structure ID ^Turanci

2XKK (Turanci)

retrieved ^Turanci

19 Oktoba 2016

4Z2C

1 reference

stated in ^Turanci

Protein Data Bank ^Turanci

PDB structure ID ^Turanci

4Z2C (Turanci)

retrieved ^Turanci

19 Oktoba 2016

5BS8

1 reference

stated in ^Turanci

Protein Data Bank ^Turanci

PDB structure ID ^Turanci

5BS8 (Turanci)

retrieved ^Turanci

19 Oktoba 2016

5CDQ

1 reference

stated in ^Turanci

Protein Data Bank ^Turanci

PDB structure ID ^Turanci

5CDQ (Turanci)

retrieved ^Turanci

19 Oktoba 2016

3FOF

1 reference

stated in ^Turanci

Protein Data Bank ^Turanci

PDB structure ID ^Turanci

3FOF (Turanci)

retrieved ^Turanci

19 Oktoba 2016

5BTA

1 reference

stated in ^Turanci

Protein Data Bank ^Turanci

PDB structure ID ^Turanci

5BTA (Turanci)

retrieved ^Turanci

19 Oktoba 2016

UMLS CUI ^Turanci

C0536495

1 reference

stated in ^Turanci